SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-029559
Filing Date
2020-10-01
Accepted
2020-10-01 16:17:43
Documents
8
Period of Report
2020-09-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ea127545-8k_greenwich.htm 8-K 29580
2 SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION ea127545ex3-1_greenwich.htm EX-3.1 40909
3 SECOND AMENDED AND RESTATED BYLAWS ea127545ex3-2_greenwich.htm EX-3.2 163406
4 EMPLOYMENT AGREEMENT BY AND BETWEEN GREENWICH LIFESCIENCES, INC. AND SNEHAL PATE ea127545ex10-1_greenwich.htm EX-10.1 87664
5 PRESS RELEASE DATED SEPTEMBER 25, 2020 ea127545ex99-1_greenwich.htm EX-99.1 9253
6 PRESS RELEASE DATED SEPTEMBER 29, 2020 ea127545ex99-2_greenwich.htm EX-99.2 9579
7 GRAPHIC image_001.gif GRAPHIC 2754
8 GRAPHIC image_002.gif GRAPHIC 2753
  Complete submission text file 0001213900-20-029559.txt   349595
Mailing Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477
Business Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477 203-434-3290
Greenwich LifeSciences, Inc. (Filer) CIK: 0001799788 (see all company filings)

IRS No.: 205473709 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39555 | Film No.: 201216099
SIC: 2834 Pharmaceutical Preparations